180 related articles for article (PubMed ID: 37909872)
1. Benefit-to-radiation-risk of low-dose computed tomography lung cancer screening.
Hendrick RE; Smith RA
Cancer; 2024 Jan; 130(2):216-223. PubMed ID: 37909872
[TBL] [Abstract][Full Text] [Related]
2. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
Rampinelli C; De Marco P; Origgi D; Maisonneuve P; Casiraghi M; Veronesi G; Spaggiari L; Bellomi M
BMJ; 2017 Feb; 356():j347. PubMed ID: 28179230
[No Abstract] [Full Text] [Related]
3. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
[TBL] [Abstract][Full Text] [Related]
5. Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT: A phantom study.
Perisinakis K; Seimenis I; Tzedakis A; Karantanas A; Damilakis J
Eur Radiol; 2018 Oct; 28(10):4370-4378. PubMed ID: 29651767
[TBL] [Abstract][Full Text] [Related]
6. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
[TBL] [Abstract][Full Text] [Related]
7. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
[TBL] [Abstract][Full Text] [Related]
8. 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.
Røe OD; Markaki M; Tsamardinos I; Lagani V; Nguyen OTD; Pedersen JH; Saghir Z; Ashraf HG
BMJ Open Respir Res; 2019; 6(1):e000512. PubMed ID: 31803478
[TBL] [Abstract][Full Text] [Related]
9. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors.
McCunney RJ; Li J
Chest; 2014 Mar; 145(3):618-24. PubMed ID: 24590022
[TBL] [Abstract][Full Text] [Related]
10. Radiation Risks in Lung Cancer Screening Programs.
McCunney RJ; Li J
Chest; 2014 Mar; 145(3):618-624. PubMed ID: 27845636
[TBL] [Abstract][Full Text] [Related]
11. Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial.
Mascalchi M; Belli G; Zappa M; Picozzi G; Falchini M; Della Nave R; Allescia G; Masi A; Pegna AL; Villari N; Paci E
AJR Am J Roentgenol; 2006 Aug; 187(2):421-9. PubMed ID: 16861547
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
14. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
[TBL] [Abstract][Full Text] [Related]
15. Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT.
Mascalchi M; Mazzoni LN; Falchini M; Belli G; Picozzi G; Merlini V; Vella A; Diciotti S; Falaschi F; Lopes Pegna A; Paci E
Br J Radiol; 2012 Aug; 85(1016):1134-9. PubMed ID: 21976631
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
[TBL] [Abstract][Full Text] [Related]
17. Low-dose computed tomography screening for lung cancer: how strong is the evidence?
Woolf SH; Harris RP; Campos-Outcalt D
JAMA Intern Med; 2014 Dec; 174(12):2019-22. PubMed ID: 25317533
[TBL] [Abstract][Full Text] [Related]
18. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
[TBL] [Abstract][Full Text] [Related]
19. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
